IL2 and neoplasm: In a preclinical study, an adenovirus encoding tumor necrosis factor-α and interleukin-2 was found that induce the formation of TLS, enhance ICB efficacy, inhibit tumor growth, and prolong survival in head and neck tumor-bearing mice [24].